You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 151 to 175 of about 5880
Next 25
02/29/2024
ADVANCED MRI BIOMARKERS PREDICT EARLY RESPONSE TO TUMOR TREATING FIELDS IN GLIOBLASTOMA
ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma
Factors associated with longer survival among older medicare patients after diagnosis of supratentorial primary brain malignancies: a retrospective cohort study
02/28/2024
The Cure Starts Now "Once in a Lifetime" Gala and Auction
02/27/2024
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
Impact of Reirradiation Utilizing Fractionated Stereotactic Radiotherapy for Recurrent Glioblastoma
02/25/2024
Theranostic Uses of the Heme Pathway in Neuro-Oncology: Protoporphyrin IX (PpIX) and Its Journey from Photodynamic Therapy (PDT) through Photodynamic Diagnosis (PDD) to Sonodynamic Therapy (SDT)
Promising Pathway Act Open House in Washington, DC This Tuesday!
02/24/2024
Biodexa Reports Positive Phase 1 Trial Results For Diffuse Midline Glioma
02/23/2024
Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro
New GT Medical CEO Per Langoe on driving adoption of brain tumor therapy
02/21/2024
Sonodynamic Therapy Webinar added to website!
02/20/2024
`Olive oil` drug shows promise in treating aggressive brain cancer at London hospital
FDA and EMA Accept Vorasidenib Regulatory Submissions for the Treatment of IDH-mutant diffuse glioma
Webinar on Sonodynamic Therapy For Brain Tumors this Wednesday 2/21/24!
02/19/2024
OurBrainBank Launches Nationwide Survey to Address Healthcare Disparities in Glioblastoma Care
02/14/2024
IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology
02/11/2024
02/09/2024
Brain cancer a thing of the past?
02/08/2024
Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients
02/07/2024
Ivy Center Announces First Patient Treated in Targeted Phase 0/1 Clinical Trial for High-Grade Glioma
02/06/2024
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification
02/03/2024
Copayment Assistance Program update!
02/02/2024
Biomarker Testing for Brain Cancer!